TY - BOOK AU - Fillit,Howard AU - O'Connell,Alan W. ED - Institute for the Study of Aging. TI - Drug discovery and development for Alzheimer's disease 2000 T2 - ISOA Annual Investigators Meeting SN - 9780826115348 AV - RC523 .D78 2002 U1 - 616.8/31061 21 PY - 2002/// CY - New York PB - Springer Pub Co. KW - Alzheimer's disease KW - Chemotherapy KW - Congresses KW - Evaluation KW - Drugs KW - Testing KW - Alzheimer Disease KW - diagnosis KW - drug therapy KW - Dementia KW - Maladie d'Alzheimer KW - Chimiothérapie KW - Congrès KW - Évaluation KW - Médicaments KW - Essais cliniques KW - HEALTH & FITNESS KW - Diseases KW - Alzheimer's & Dementia KW - bisacsh KW - MEDICAL KW - Neurology KW - fast KW - Alzheimerkrankheit KW - gnd KW - Pharmakotherapie KW - Nootropikum KW - Pharmakologie KW - Congress KW - proceedings (reports) KW - aat KW - Conference papers and proceedings KW - lcgft KW - Actes de congrès KW - rvmgf N1 - Includes bibliographical references and index; 1. The Challenges of Drug Discovery and Drug Development for Cognitive Aging and Alzheimer's Disease / Howard Fillit and Alan O'Connell -- pt. I. Early Detection -- 2. Genetic Correlates of Successful Cognitive Aging / Thomas Perls -- 3. Genetic and Environmental Risk Factors for Alzheimer's Disease in Arabs Residing in Israel / Robert P. Friedland, Amos Korczyn and Lindsay Farrer -- 4. Telephonic Screening of Mental Status: A Feasibility Study in a Managed Care Clinic / David Knopman, Thomas Vonsternberg and Jim Haefemeyer -- 5. Use of Brain MRI Volumetric Analysis in a Mild Cognitive Impairment Trial to Delay the Diagnosis of Alzheimer's Disease / Michael Grundman, Drahomira Sencakova and Clifford R. Jack, Jr. / [and others] -- 6. Hippocampal Volume Assessment in Mild Cognitive Impairment / Michael S. Mega, Paul M. Thompson and Arthur W. Toga / [and others] -- 7. Brain Imaging Surrogate Markers for Detection and Prevention of Cognitive Aging and Alzheimer's Disease / Gary W. Small -- 8. Novel [beta]-Amyloid Probes / Mei-Ping Kung, Zhi-Ping Zhuang and Catherine Hou / [and others] -- 9. Early Clinical and Biological Manifestations of Alzheimer's Disease: Implications for Screening and Treatment / Richard C. Mohs, Deborah Marin and Vahram Haroutunian -- pt. II. Drug Discovery -- 10. Identification of Brain-Expressed ABC Transporters That May Mediate Detachment of [beta]-Amyloid From Biological Membranes / Peter B. Reiner and Stephane Le Bihan -- 11. Targeting an RNA Structure in the Amyloid Precursor Protein Gene as a New Therapeutic Strategy for Alzheimer's Disease / Jack T. Rogers -- 12. Novel Tricyclic Pyrone Compounds Prevent Intracellular APP C99-Induced Cell Death / Lee-Way Jin, Duy H. Hua and Feng-Shiun Shie / [and others] -- 13. Novel Glycosaminoglycans as Antiamyloid Agents / Robert Kisilevsky and Walter A. Szarek -- 14. Strategies for Inhibiting Alzheimer's [gamma]-Secretase / Michael S. Wolfe -- 15. Phosphorylations of Tau and APP as Targets for Drug Discovery / John DeBernardis, Dan Kerkman and Cintia Vianna / [and others] -- 16. Estrogen and ApoE: Drug Discovery Implications / Jonathan D. Smith and Justine A. Levin -- 17. Structure-Based Functional Design of Agonists and Antagonists for AMPA-Subtype Glutamate Receptors / Ming-Ming Zhou, Harel Weinstein and Diomedes E. Logothetis / [and others] -- 18. Alzheimer's Therapeutics: Neurotrophin Small Molecule Mimetics / Stephen M. Massa, You-Mei Xie and Frank M. Longo -- pt. III. Drug Development -- Preclinical -- 19. Antioxidants in the Treatment of Alzheimer's Disease: Breakthrough Potential of Indole-3-Propionic Acid / Daniel G. Chain, Douglas Galasko and Eyal Neria / [and others] -- 20. AF150(S) and AF267B: M1 Muscarinic Agonists for Treatment and as Disease-Modifying Agents in Alzheimer's and Related Diseases / A. Fisher, Z. Pittel and R. Brandeis / [and others] -- 21. ABS-205: Effects on Cognition in Mature and Aged Rats / Ciaran M. Regan -- 22. Calpain Inhibitors: A Treatment of Alzheimer's Disease / Ottavio Arancio -- 23. Femtomolar-Acting Neuroprotective Peptides: Application for Inhibition of Alzheimer's Disease / Illana Gozes, Sharon Furman and Ruth A. Steingart / [and others] -- pt. IV. Drug Development -- Clinical -- 24. A Phase I Clinical Study of Ex Vivo Nerve Growth Factor Gene Therapy for Alzheimer's Disease / Mark H. Tuszynski -- 25. Lowering Homocysteine Levels in Patients With Alzheimer's Disease / Paul Aisen, Mary Sano and Ramon Diaz-Arrastia / [and others] -- 26. Therapeutic Potential of Positive AMPA Receptor Modulators in Mild Cognitive Impairment and Alzheimer's Disease / Steven A. Johnson, Gary Lynch and Gary A. Rogers / [and others] -- 27. The Alzheimer's Disease Atorvastatin Treatment Trial: Scientific Basis and Position on the Use of HMG-CoA Reductase Inhibitors (Statins) That Do or Do Not Cross the Blood-Brain Barrier / D. Larry Sparks, Donald J. Connor and Patrick J. Browne / [and others] -- 28. A Double-Blind, Randomized Investigation of the Effects of Testosterone or Placebo in Male Patients With Mild-to-Moderate Alzheimer's Disease / Bruce Miller -- 29. Estrogen and Cognitive Functioning in Men With Mild Cognitive Impairment / Barbara B. Sherwin and Howard Chertkow; Electronic reproduction; [Place of publication not identified]; HathiTrust Digital Library; 2010 N2 - This prestigious volume presents the findings of an international group of academic and biotechnological researchers. Topics range from early detection programs focusing on genetic factors, novel probes for detecting B-amyloid in the living brain, and the use of telephonic screening and MRI's to the diversity of therapeutic areas such as antioxidants, estrogen agonists and various anti-B-amyloid and anti-tangle approaches. The volume is still an indispensable resource for the psychogeriatrician, psychiatrist, clinical investigator, and neurobiologist, and a must for medical libraries UR - https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=246181 ER -